Evaluation of ADX10059 to prevent migraine attacks
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
350
Unnamed facility
Vienna, Austria
Liège
Liège, Belgium
Number of migraine headache days during weeks 9-12 of the treatment period
Time frame: 12 weeks
Migraine frequency
Time frame: 12 weeks
Migraine severity
Time frame: 12 weeks
Migraine duration
Time frame: 12 weeks
Occurrence of aura
Time frame: 12 weeks
Functional impairment severity
Time frame: 12 weeks
Rescue medication use
Time frame: 12 weeks
Proportion of responders
Time frame: 12 weeks
Global assessment of study medication
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Oral administration
Sint-Truiden
Sint-Truiden, Belgium
Wilrijk
Wilrijk, Belgium
Lille
Lille, France
Nice
Nice, France
Paris
Paris, France
Toulouse
Toulouse, France
06
Berlin, Germany
Berlin Hellersdorf 11
Berlin, Germany
...and 21 more locations